JP2022542805A5 - - Google Patents
Info
- Publication number
- JP2022542805A5 JP2022542805A5 JP2022502219A JP2022502219A JP2022542805A5 JP 2022542805 A5 JP2022542805 A5 JP 2022542805A5 JP 2022502219 A JP2022502219 A JP 2022502219A JP 2022502219 A JP2022502219 A JP 2022502219A JP 2022542805 A5 JP2022542805 A5 JP 2022542805A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- acid sequence
- fragment
- antibody
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962874340P | 2019-07-15 | 2019-07-15 | |
| US62/874,340 | 2019-07-15 | ||
| PCT/US2020/042064 WO2021011608A1 (en) | 2019-07-15 | 2020-07-15 | Metallothionein antibodies and their use |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022542805A JP2022542805A (ja) | 2022-10-07 |
| JP2022542805A5 true JP2022542805A5 (https=) | 2023-07-20 |
| JP7669339B2 JP7669339B2 (ja) | 2025-04-28 |
Family
ID=71895285
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022502219A Active JP7669339B2 (ja) | 2019-07-15 | 2020-07-15 | メタロチオネイン抗体およびそれらの使用 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US12466877B2 (https=) |
| EP (1) | EP3999531A1 (https=) |
| JP (1) | JP7669339B2 (https=) |
| KR (1) | KR20220034811A (https=) |
| CN (2) | CN114127105B (https=) |
| AU (1) | AU2020315367A1 (https=) |
| BR (1) | BR112022000705A2 (https=) |
| CA (1) | CA3144014A1 (https=) |
| IL (1) | IL289843A (https=) |
| MX (1) | MX2022000642A (https=) |
| PH (1) | PH12022550097A1 (https=) |
| WO (1) | WO2021011608A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN121002061A (zh) * | 2023-01-12 | 2025-11-21 | 弗吉尼亚大学专利基金委员会 | 抗cith3抗体及其用途 |
| WO2025149667A1 (en) | 2024-01-12 | 2025-07-17 | Pheon Therapeutics Ltd | Antibody drug conjugates and uses thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103201290B (zh) * | 2010-06-14 | 2016-09-28 | 莱克拉生物医学股份公司 | S100a4抗体及其治疗用途 |
| US20140141009A1 (en) * | 2011-07-08 | 2014-05-22 | Univeristy Of Connecticut | Use of antagonists targeting metallothionein to treat intestinal inflammation |
| EP3740282B1 (en) * | 2018-01-17 | 2025-03-26 | University of Connecticut | Metallothionein inhibitors for treating diabetes, hepatitis, and/or inflammatory liver disease |
-
2020
- 2020-07-15 AU AU2020315367A patent/AU2020315367A1/en active Pending
- 2020-07-15 EP EP20750116.4A patent/EP3999531A1/en active Pending
- 2020-07-15 BR BR112022000705A patent/BR112022000705A2/pt unknown
- 2020-07-15 US US17/625,476 patent/US12466877B2/en active Active
- 2020-07-15 CN CN202080051788.2A patent/CN114127105B/zh active Active
- 2020-07-15 WO PCT/US2020/042064 patent/WO2021011608A1/en not_active Ceased
- 2020-07-15 KR KR1020227003374A patent/KR20220034811A/ko active Pending
- 2020-07-15 MX MX2022000642A patent/MX2022000642A/es unknown
- 2020-07-15 CN CN202411420348.6A patent/CN119285765A/zh active Pending
- 2020-07-15 JP JP2022502219A patent/JP7669339B2/ja active Active
- 2020-07-15 PH PH1/2022/550097A patent/PH12022550097A1/en unknown
- 2020-07-15 CA CA3144014A patent/CA3144014A1/en active Pending
-
2022
- 2022-01-13 IL IL289843A patent/IL289843A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7559112B2 (ja) | グルカゴン様ペプチド１受容体アゴニストおよびそれらの使用 | |
| JP2023061927A5 (https=) | ||
| JP2024532619A5 (https=) | ||
| JP2018535948A5 (https=) | ||
| EP3241850A1 (en) | Glp and immunoglobulin hybrid fc fused polypeptide and use thereof | |
| JP2020528894A5 (https=) | ||
| KR20070004078A (ko) | 인간 ｇｌｐ-1 모방체, 조성물, 방법 및 용도 | |
| KR20230117462A (ko) | 응고 제 ix 인자 및/또는 활성화 응고 제 ix 인자 및응고 제 x 인자 및/또는 활성화 응고 제 x 인자를 인식하는 이중특이성 항체의 사용법 | |
| KR20070090036A (ko) | Ｇｌｐ-1 작용제, 조성물, 방법 및 용도 | |
| JP7486423B2 (ja) | 糖尿病、肝炎、および／または炎症性肝疾患を治療するための方法 | |
| JP2022542805A5 (https=) | ||
| JP2021511296A5 (https=) | ||
| JP2016520058A (ja) | 抗グルカゴン受容体抗体およびその使用方法 | |
| CN105801705A (zh) | 含胰高血糖素样肽-1和免疫球蛋白杂合Fc的融合多肽及其用途 | |
| JP2016528198A5 (https=) | ||
| CN114630681A (zh) | 包含actrii受体拮抗剂的肝疾病或障碍的治疗 | |
| KR20080074136A (ko) | 항체의 생성에 있어서의 ｂ 세포 팽창제의 사용 | |
| JP2025529933A (ja) | ＡｃｔＲＩＩ抗体固定単位用量の治療 | |
| JP7669339B2 (ja) | メタロチオネイン抗体およびそれらの使用 | |
| Qi et al. | Therapeutic effects of different doses of polyethylene glycosylated porcine glucagon-like peptide-2 on ulcerative colitis in male rats | |
| TW202506169A (zh) | 用於治療噁心及嘔吐之方法及用途 | |
| EA048185B1 (ru) | Антитела к металлотионеину и их применение | |
| JPWO2020204033A5 (https=) | ||
| WO2025180387A1 (en) | Super long-lasting glp1 or glp1/gip analogue drugfor type-2 diabetes and obesity | |
| CN118021955A (zh) | 用于治疗il-17a介导的疾病或病症的方法和组合物 |